Søby, S. et al. 2022. Efficacy of nivolumab as second line treatment for recurrent or metastatic head and neck squamous cell carcinoma: a national DAHANCA cohort study. Acta Oncologica. 61, 8 (Aug. 2022), 972–978. DOI:https://doi.org/10.1080/0284186X.2022.2103387.